Clinical evaluation of hemochromatosis with end-stage renal disease.
- Author:
Byung Don CHOI
1
;
Hye Won JOO
;
Kyung Pil KANG
;
Min Suk PARK
;
Min Geun KIM
;
Sang Hyun KIM
;
Won Do PARK
Author Information
1. Department of Internal Medicine, Inje University College of Medicine, Sanggaepaik Hospital, Seoul, Korea. Wondoful1958@naver.com
- Publication Type:Case Report
- Keywords:
Hemochromatosis;
Chronic kidney failure;
Renal dialysis
- MeSH:
Anemia;
Biopsy;
Blood Transfusion;
Deferoxamine;
Erythropoietin;
Ferritins;
Hemochromatosis*;
Humans;
Iron;
Iron Overload;
Kidney Failure, Chronic*;
Liver;
Renal Dialysis
- From:Korean Journal of Medicine
2007;72(2):237-241
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hemochromatosis is almost always a consequence of treatment for anemia in long term hemodialysis patients who have undergone frequent blood transfusions and iron therapy. Clinically, iron overload may be a serious problem for some maintenance hemodialysis patients and it may be manifested as organ dysfunctions. So, it is important to diagnose iron overload early and restrict blood transfusions and the administration of iron agents in these patients. We recently experienced one case of suspected primary hemochromatosis in a long term hemodialysis patient, and we evaluated the patient by checking the serum ferritin level and performing liver biopsy. Treatment with desferrioxamine was started with recombinant erythropoietin. We report on this case with a brief review of the literature.
